Homocysteine and Cardiovascular Disease
Authors:
- 15 September 2006
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 99 (6) , 565-566
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Hyperhomocysteinemia Decreases Circulating High-Density Lipoprotein by Inhibiting Apolipoprotein A-I Protein Synthesis and Enhancing HDL Cholesterol ClearanceCirculation Research, 2006
- Elevated Homocysteine Reduces Apolipoprotein A-I Expression in Hyperhomocysteinemic Mice and in Males With Coronary Artery DiseaseCirculation Research, 2006
- Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary DiseaseNew England Journal of Medicine, 2001
- Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarctionClinical Biochemistry, 2001
- Homocysteine and Cardiovascular DiseaseAnnual Review of Medicine, 1998
- Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AINature, 1991
- Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.Journal of Clinical Investigation, 1990
- Incidence of Coronary Heart Disease and Lipoprotein Cholesterol LevelsJAMA, 1986
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- The pathogenesis of coronary artery disease. A possible role for methionine metabolism.Journal of Clinical Investigation, 1976